Plasmodium species blood-stage parasites (Plasmodium spp.)

Plasmodium spp. blood-stage parasites are the asexual forms of the malaria-causing protozoa that infect and replicate within human erythrocytes. This stage of the life cycle is exclusively responsible for the clinical manifestations of malaria, including fever, anemia, and potential organ failure (CDC, 2023) [1]. During this phase, parasites consume host hemoglobin to obtain essential amino acids, a process that releases toxic heme which the parasite must detoxify into inert hemozoin crystals (Goldberg, 1990) [2]. The biological processes within this stage, such as heme detoxification, DNA synthesis, and nutrient transport, serve as the primary targets for the majority of current antimalarial therapies (WHO, 2023) [3]. Drugs like chloroquine interfere with hemozoin formation, while artemisinins generate reactive oxygen species that damage parasite proteins and membranes (Ashley et al., 2014) [5]. Effective clearance of blood-stage parasites is the cornerstone of malaria treatment and is monitored via parasitemia levels or diagnostic biomarkers like PfHRP2 and pLDH (Moody, 2002) [4]. However, the emergence of multi-drug resistance, particularly in Plasmodium falciparum, remains a significant global health challenge (Ashley et al., 2014) [5].

Other names

Erythrocytic stage PlasmodiumMalarial blood-stage parasitesPlasmodium falciparumPlasmodium vivaxPlasmodium ovalePlasmodium malariaePlasmodium knowlesi

Inhibition of heme detoxification; Inhibition of dihydrofolate reductase; Disruption of mitochondrial electron transport; Generation of free radicals via endoperoxide activation; Inhibition of parasite protein synthesis